EarthEssences-AAVO-HIV..AIDS...EarthEssences-AAVO..HIV-AIDS...HIV

 AAVO-AIDS-HIV-Agenerase (amprenavir)

  • Classification: Due to the popularity of Lexiva (fosamprenavir), Agenerase is no longer available. If you are taking Agenerase, contact your doctor for further instructions.
  • Kaletra (Lopinavir + Norvir)
  • Classification:Protease Inhibitor (PI)
  • Form:Capsules containing 133mg of Lopinavir and 33mg of Norvir that acts as a PI booster.
  • Dosage:Three capsules twice each day.
  • Four capsules twice per day when used with Sustiva or Viramune.
  • Instructions:Kaletra should be taken with food.
  • Capsules should be refrigerated and kept out of extreme heat to avoid melting.
  • Side effects to report to your physician:
  •  Fatigue
  •  Headache
  • Nausea / vomiting / diarrhea
  • Elevated cholesterol and triglycerides
  • Drug interactions or incompatibility:
  • Viagra doses need to be lowered when taking any PI.
  • Do not take St. John's Wort when taking a PI.
  • The individual drug Norvir should not be taken in combination with Kaletra.

  • Protease Inhibitor (PI)
  • Form:
  • 150mg capsules
  • Dosage:
  • Eight 150mg capsules twice each day.
  • Instructions:
  • May be taken with or without food, but taking with food will help ease nausea.
  • Side effects to report to your doctor:
  • Headache
  • Increased cholesterol and triglycerides levels
  • Nausea / vomiting / diarrhea
  • Abdominal pain
  • Rash (should be reported immediately)
  • Numbing sensation of the skin
  •  Increased blood sugar (characterized by increased thirst, weight loss, increased urination, and fatigue)

  • Drug interactions or incompatibility:
  • Agenerase also contains vitamin E, therefore vitamin E supplements should not be used while taking Agenerase.
  • The drugs Hismanal, Propulsid, Halcion or Versed should not be taken with Agenerase.
  • Rifampin (a treatment for TB) lowers Agenerase levels in the blood and therefore should not be used

Home                   Channels

Womens Health

EARTH-ESSENCES-HOME PAGE